D'Aversa G - Search Results

1

Contextual Factors-Enriched Standard Care on mechanical neck pain (ContextualizAR trial): Protocol for a randomised controlled trial.

Andreu MF, Soliño S, Villalba F, Policastro PO, Laurens ML, D'Aversa G, Mastandrea M, Rodriguez F, Ramirez A, Cook C, Rossettini G. Andreu MF, et al. Among authors: d aversa g. Musculoskeletal Care. 2024 Jun;22(2):e1894. doi: 10.1002/msc.1894. Musculoskeletal Care. 2024. PMID: 38712487

2

Matrix Fourier optics enables a compact full-Stokes polarization camera.

Rubin NA, D'Aversa G, Chevalier P, Shi Z, Chen WT, Capasso F. Rubin NA, et al. Among authors: d aversa g. Science. 2019 Jul 5;365(6448):eaax1839. doi: 10.1126/science.aax1839. Science. 2019. PMID: 31273096

3

Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery.

Rosenberg ED, Nattis AS, Alevi D, Chu RL, Bacotti J, LoPinto RJ, D'Aversa G, Donnenfeld ED. Rosenberg ED, et al. Among authors: d aversa g. Clin Ophthalmol. 2017 Dec 21;12:21-28. doi: 10.2147/OPTH.S149581. eCollection 2018. Clin Ophthalmol. 2017. PMID: 29317798 Free PMC article.

4

Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.

Rajpal RK, Digby D, D'Aversa G, Mah F, Hollander DA, Conway T. Rajpal RK, et al. Among authors: d aversa g. J Ocul Pharmacol Ther. 2011 Jun;27(3):305-8. doi: 10.1089/jop.2010.0182. Epub 2011 May 16. J Ocul Pharmacol Ther. 2011. PMID: 21574815

5

The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.

Su MY, Perry HD, Barsam A, Perry AR, Donnenfeld ED, Wittpenn JR, D'Aversa G. Su MY, et al. Among authors: d aversa g. Cornea. 2011 Oct;30(10):1098-104. doi: 10.1097/ICO.0b013e318206caee. Cornea. 2011. PMID: 21407074 Clinical Trial.

6

Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: tools for predicting response.

McDonald M, D'Aversa G, Perry HD, Wittpenn JR, Nelinson DS. McDonald M, et al. Among authors: d aversa g. Curr Eye Res. 2010 Oct;35(10):880-7. doi: 10.3109/02713683.2010.495811. Curr Eye Res. 2010. PMID: 20858108

7

Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry.

Luchs JI, Nelinson DS, Macy JI; LAC-07-01 Study Group. Luchs JI, et al. Cornea. 2010 Dec;29(12):1417-27. doi: 10.1097/ICO.0b013e3181e3f05b. Cornea. 2010. PMID: 20847657 Clinical Trial.

8

Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry.

Koffler BH, McDonald M, Nelinson DS; LAC-07-01 Study Group. Koffler BH, et al. Eye Contact Lens. 2010 May;36(3):170-6. doi: 10.1097/ICL.0b013e3181db352f. Eye Contact Lens. 2010. PMID: 20351555

9

Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life.

McDonald M, D'Aversa G, Perry HD, Wittpenn JR, Donnenfeld ED, Nelinson DS. McDonald M, et al. Among authors: d aversa g. Trans Am Ophthalmol Soc. 2009 Dec;107:214-21. Trans Am Ophthalmol Soc. 2009. PMID: 20126497 Free PMC article.

10

Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid.

Donnenfeld ED, Perry HD, Wallerstein A, Caronia RM, Kanellopoulos AJ, Sforza PD, D'Aversa G. Donnenfeld ED, et al. Among authors: d aversa g. Ophthalmology. 1999 Jan;106(1):72-8; discussion 79. doi: 10.1016/S0161-6420(99)90022-2. Ophthalmology. 1999. PMID: 9917784 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters